Haemophilus Influenzae Pneumonia in Adults
Key facts
- Who runs it
- Assistance Publique - Hôpitaux de Paris
- Where
- France12 sites in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 203 people enrolled
- Started
- 26 Jul 2024
- Ended
- 1 Sept 2024
- Type of study
- Observational
- Treatments tested
- Collection of data from the patient's medical file
- Record updated
- 15 June 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 9 criteriaShow less
Who can take part
- Acute respiratory symptoms: cough and/or dyspnea and/or purulent sputum or worsening of the color of the sputum for patients with chronic respiratory pathology, chest pain, desaturation defined by saturation < 95% in ambient air
- Inflammatory syndrome: fever ≥ 38.5°C or CRP ≥ 30 mg/L
- Pulmonary imaging (x-ray or CT scan) compatible with pneumonia
- Good quality respiratory sample (for cytobacteriological examination of sputum (CBES) : leukocytes > 25/mm3 and cells < 10/mm3) positive in culture for H. influenzae at a significant threshold (for CBES ≥ 107 CFU/mL, for "standard" bronchial aspirate ≥ 105 CFU/mL, for protected bronchial aspiration ≥ 103 CFU/mL, for bronchoalveolar lavage ≥ 104 CFU/mL)
- Respiratory antibiotic therapy started by the clinician
Who cannot take part
- Age < 18 years
- Opposition formulated (following receipt of the study information note)
- Legal protection measure (impossibility of collecting non-opposition)
- Ventilator-associated pneumonia (VAP)
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Haemophilus influenzae is a Gram-negative coccobacillus capable of colonizing and infecting the human respiratory tract.
Read full original descriptionShow less
In the adult population, patients with an abnormality of their mucociliary epithelium and a deficiency in innate or adaptive immunity are particularly exposed.
The Infectious and Tropical Diseases department of Necker-Enfants Malades hospital has noted a recent increase in the number of cases of respiratory infections due to H. influenzae, with a high frequency of early relapses and recurrences despite appropriate treatment.
The research focuses on lower respiratory infections (pneumonia) caused by Haemophilus influenzae in adults, excluding pneumonia acquired under mechanical ventilation linked to Haemophilus influenzae in patients in 13 AP-HP hospitals during 12 months, from 09/01/2022 to 08/31/2023.
The group in the trial
- Patients
Hospitalized patients for a Haemophilus influenzae pneumonia in 13 AP-HP hospitals between 09/01/2022 to 08/31/2023.
Treatment: Collection of data from the patient's medical file
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Retrospective Hospital Study of Haemophilus Influenzae Pneumonia in Adults: Relapse and Severity
- Record updated
- 15 June 2026